Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALAI.L Regulatory News (ALAI)

  • There is currently no data for ALAI

Directorate Change

19 Aug 2020 12:25

RNS Number : 6094W
Aberdeen Latin American Inc Fd Ltd
19 August 2020
Ā 

ABERDEEN LATIN AMERICAN INCOME FUND LIMITED

Legal Entity Identifier (LEI): 549300DN623WEGE2MY04

Ā 

Appointment of Non-Executive Director

Ā 

19 August 2020

Ā 

The Board of Aberdeen Latin American Income Fund Limited (the "Company") is pleased to announce the appointment of Howard Myles as an independent non-executive Director of the Company with effect from 1 October 2020. Mr Myles was appointed after a search conducted by an independent recruitment consultancy.

Ā 

Richard Prosser, Chairman of the Company, said: "The Directors are delighted to welcome Howard to the Board. Howard brings a wealth of knowledge in relation to closed-end funds including experience of the Latin American region.

Ā 

He was a partner with Ernst & Young from 2001 to 2007 and was responsible for the Investment Funds Corporate Advisory team having previously been with UBS Warburg. Starting his career as an equity salesman, he then joined Touche Ross & Co in 1975 where he qualified as a chartered accountant. In 1978 he joined W Greenwell & Co. in the corporate broking team and in 1987 moved to SG Warburg Securities where he was involved in a wide range of commercial and industrial transactions in addition to leading Warburg's corporate finance function for investment funds.

Ā 

Howard is currently Senior Independent Director of BBGI SICAV and Audit Committee Chair of Chelverton UK Dividend Trust plc. He is Chairman of JP Morgan Brazil Investment Trust plc, from which he is due to retire on 17 September 2020, and Chairman of Baker Steel Resources Trust Limited."

Ā 

Mr Myles will stand for election as a Director at the Annual General Meeting to be held on or around 10 December 2020.

Ā 

In accordance with paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules, Mr Myles advises that, within the last five years, he stepped down as a non-executive Director of Lazard World Trust Fund in 2019 and Aberdeen Private Equity Fund Limited in 2018.

Ā 

There are no other disclosures required to be made for Mr Myles in respect of paragraphs 9.6.13 (1) - (6) of the Financial Conduct Authority's Listing Rules.

Ā 

Mr Myles does not hold any interests in any of the Company's shares.

Ā 

Ā 

Aberdeen Standard Capital International Limited

Company Secretary

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Ā 
END
Ā 
Ā 
BOAKKCBBDBKDNFD
Date   Source Headline
7th Jun 20221:23 pmRNSNet Asset Value(s)
6th Jun 20224:54 pmRNSGearing disclosure
6th Jun 20224:06 pmRNSQuarterly disclosure
6th Jun 20222:44 pmRNSNet Asset Value(s)
31st May 202212:43 pmRNSNet Asset Value(s)
30th May 20223:51 pmRNSGearing disclosure
30th May 202212:37 pmRNSNet Asset Value(s)
27th May 20221:13 pmRNSNet Asset Value(s)
26th May 202212:56 pmRNSNet Asset Value(s)
25th May 20221:23 pmRNSNet Asset Value(s)
24th May 202212:25 pmRNSNet Asset Value(s)
23rd May 20224:14 pmRNSGearing disclosure
23rd May 20221:07 pmRNSNet Asset Value(s)
20th May 202212:44 pmRNSNet Asset Value(s)
19th May 202212:27 pmRNSNet Asset Value(s)
18th May 20224:55 pmRNSPortfolio disclosure
18th May 202212:47 pmRNSNet Asset Value(s)
17th May 20221:02 pmRNSNet Asset Value(s)
16th May 20225:00 pmRNSDoc re. Half Yearly Report
16th May 20224:08 pmRNSGearing disclosure
16th May 20221:08 pmRNSNet Asset Value(s)
13th May 20221:00 pmRNSNet Asset Value(s)
12th May 202212:32 pmRNSNet Asset Value(s)
11th May 202212:42 pmRNSNet Asset Value(s)
10th May 20221:04 pmRNSNet Asset Value(s)
9th May 20222:08 pmRNSGearing disclosure
9th May 20221:20 pmRNSNet Asset Value(s)
6th May 20225:17 pmRNSMonth End Net Asset Value(s)
6th May 202212:08 pmRNSNet Asset Value(s)
5th May 202212:30 pmRNSNet Asset Value(s)
4th May 202212:46 pmRNSNet Asset Value(s)
4th May 20227:00 amRNSHalf-year Report
3rd May 20225:50 pmRNSGearing Disclosures
29th Apr 202211:37 amRNSNet Asset Value(s)
28th Apr 202212:13 pmRNSNet Asset Value(s)
27th Apr 202212:52 pmRNSNet Asset Value(s)
26th Apr 20222:14 pmRNSSecond Interim Dividend
26th Apr 202212:37 pmRNSNet Asset Value(s)
25th Apr 20222:51 pmRNSGearing Disclosure
25th Apr 20221:05 pmRNSNet Asset Value(s)
22nd Apr 20221:21 pmRNSNet Asset Value(s)
21st Apr 202212:38 pmRNSNet Asset Value(s)
20th Apr 202212:28 pmRNSNet Asset Value(s)
19th Apr 20226:00 pmRNSGearing Disclosure
19th Apr 20221:07 pmRNSNet Asset Value(s)
19th Apr 202210:19 amRNSPortfolio Disclosures
14th Apr 202212:39 pmRNSNet Asset Value(s)
13th Apr 202212:05 pmRNSNet Asset Value(s)
12th Apr 202212:26 pmRNSNet Asset Value(s)
11th Apr 20222:13 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.